Jonathan McNeill
Corporate Officer/Principal bij DYNE THERAPEUTICS, INC.
Vermogen: 3 M $ op 30-04-2024
Profiel
Jonathan McNeill is currently the Chief Business Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as the Associate Director-Business Development at Editas Medicine, Inc. from 2015 to 2019.
Dr. McNeill received his graduate degree from the University of Pennsylvania in 2014 and his undergraduate degree from The University of North Carolina at Chapel Hill in 2007.
He also holds a doctorate degree from Perelman School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DYNE THERAPEUTICS INC
0.16% | 16-05-2024 | 136 634 ( 0.16% ) | 3 M $ | 30-04-2024 |
Actieve functies van Jonathan McNeill
| Bedrijven | Functie | Begin |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2019 |
Eerdere bekende functies van Jonathan McNeill
| Bedrijven | Functie | Einde |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01-01-2019 |
Opleiding van Jonathan McNeill
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
